2023 Biotechnology Mergers and acquisition activities 
Frost & Sullivan
MAY 9, 2025
Industry Consolidation and Strategic Acquisitions Major CROs are expanding their service portfolios through mergers and acquisitions. These tools enhance patient recruitment, optimize protocol design, and improve real-world data (RWD) utilization.
Frost & Sullivan
JANUARY 23, 2025
Key Trends and Growth Opportunities Focus on Mergers & Acquisitions (M&A) Driving Industry Consolidation M&A activity emerged as a dominant theme at JPM 2025, with deals exceeding $18 billion announced during the conference. billion acquisition of Scorpion Therapeutics , adding a promising PI3K inhibitor program.
Expert insights. Personalized for you.
52 
Let's personalize your content